The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-β Exposure
Open accessAbstract
This study evaluated the respiratory indexes (respiratory control ratio [RCR] and ADP/O ratio), mitochondrial transmembrane potential (ΔΨm), repolarization lag phase, repolarization level, ATP/ADP ratio, and induction of the permeability transition pore of brain mitochondria isolated from normal Wistar and GK diabetic rats of different ages (1.5, 12, and 24 months of age). The effect of amyloid β-peptides, 50 μmol/l Aβ25–35 or 2 μmol/l Aβ1–40, on mitochondrial function was also analyzed. Aging of diabetic mice induced a decrease in brain mitochondrial RCR, ADP/O, and ATP/ADP ratios but induced an increase in the repolarization lag phase. Brain mitochondria from older diabetic rats were more prone to the induction of the permeability transition pore, i.e., mitochondria from 24-month-old diabetic rats accumulated much less Ca2+ (20 μmol/l) than those isolated from 12-month-old rats (50 μmol/l) or 1.5-month-old rats (100 μmol/l). In the presence of 50 μmol/l Aβ25–35 or 2 μmol/l Aβ1–40, age-related mitochondrial effects were potentiated. These results indicate that diabetes-related mitochondrial dysfunction is exacerbated by aging and/or by the presence of neurotoxic agents such as amyloid β-peptides, supporting the idea that diabetes and aging are risk factors for the neurodegeneration induced by these peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a mitochondrial injury may play a role in transitioning from diabetes to AD, as exposing diabetic rats’ brain mitochondria to Aβ increases their vulnerability. 105”
From Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications (2024) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTION
Gornall, A. G., Bardawill, C. J., & David, M. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57021-6 · Cited by 16,164
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
The mitochondrial permeability transition
Zoratti, M., & Szabó, I. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00003-a · Cited by 2,410
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
[7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios
Estabrook, R. W. (1967) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(67)10010-4 · Cited by 1,781
Kamo, N., Muratsugu, M., Hongoh, R., & Kobatake, Y. (1979) · The Journal of Membrane Biology · doi:10.1007/bf01868720 · Cited by 956
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Cited by
Sorted by citations
VDAC, a multi-functional mitochondrial protein regulating cell life and death
Shoshan‐Barmatz, V., Pinto, V. D., Zweckstetter, M., Raviv, Z., Keinan, N., & Arbel, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.03.002 · Cited by 824
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734
Self-citationMitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2018 · Cited by 447
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Akter, K., Lanza, E. A., Martin, S. A., Myronyuk, N., Rua, M., & Raffa, R. B. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03830.x · Cited by 352
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Alharbi, S. H. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231222367 · Cited by 358
Insulin in Central Nervous System: More than Just a Peripheral Hormone
Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 337
Self-citationAlzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits
Chatterjee, S., & Mudher, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00383 · Cited by 270
Diabetes and Alzheimer’s disease crosstalk
Baglietto‐Vargas, D., Shi, J. J., Yaeger, D. M., Ager, R. R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 263
Aleardi, A. M., Benard, G., Augereau, O., Malgat, M., Talbot, J.-C., Mazat, J., Letellier, T., Dachary-Prigent, J., Solaini, G., & Rossignol, R. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-6631-3 · Cited by 227
Molecular links between Alzheimer’s disease and diabetes mellitus
Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 211
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 202
Self-citationBrain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes
Moreira, P. I., Santos, M. S., Seiça, R. M. F., & Oliveira, C. R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.017 · Cited by 190
Self-citationInside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline
Gaspar, J. M., Baptista, F. I., Macedo, M. P., & Ambrósio, A. F. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00240 · Cited by 183
Multiple Defects in Energy Metabolism in Alzheimers Disease
Ferreira, I. L., Resende, R., Ferreiro, E. B., Rego, A. C., & Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 185
Leissring, M. A., Farris, W., Wu, X., Christodoulou, D. C., Haigis, M. C., Guarente, L., & Selkoe, D. J. (2004) · Biochemical Journal · doi:10.1042/bj20041081 · Cited by 168
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100666 · Cited by 162
Self-citationCarvalho, C., Cardoso, S., Correia, S. C., Santos, R. X., Santos, M. S., Baldeiras, I., Oliveira, C. R., & Moreira, P. I. (2012) · Diabetes · doi:10.2337/db11-1186 · Cited by 159
Self-citationAlzheimer's Disease: A Lesson from Mitochondrial Dysfunction
Moreira, P. I., Santos, M. S., & Oliveira, C. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1703 · Cited by 155
Self-citationThe key role of mitochondria in Alzheimer's disease
Moreira, P. I., Cardoso, S. M., Santos, M. S., & Oliveira, C. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9202 · Cited by 151
Self-citationMitoenergetic failure in Alzheimer disease
Parihar, M. S., & Brewer, G. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2006 · Cited by 153
Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Plácido, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.008 · Cited by 149
Self-citationVercesi, A. E., Castilho, R. F., Kowaltowski, A. J., Oliveira, H. C. F., de Souza-Pinto, N. C., Figueira, T. R., & Busanello, E. N. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.034 · Cited by 146
Marques‐Aleixo, I., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.002 · Cited by 134
Self-citationMarzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 126
Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
Belosludtsev, K. N., Belosludtseva, N. V., & Dubinin, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186559 · Cited by 124
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Europe PMC (PubMed Central) · Cited by 120
Self-citationThe GK Rat: A Prototype for the Study of Non-overweight Type 2 Diabetes
Portha, B., Giroix, M.-H., Tourrel‐Cuzin, C., Stunff, H. L., & Movassat, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-068-7_9 · Cited by 120
Long, J., Liu, C., Sun, L., Gao, H., & Liu, J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9882-7 · Cited by 110
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
Su, X., Floyd, D. H., Hughes, A., Xiang, J., Schneider, J. G., Uluçkan, Ö., Heller, E., Deng, H., Zou, W., Craft, C. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38576 · Cited by 104
Metabolic Alterations Associated to Brain Dysfunction in Diabetes
Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.1104 · Cited by 107
Long, J., He, P., Shen, Y., & Li, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120283 · Cited by 102
Moreira, P. I., Santos, M. S., Sena, C. M., NUNES, E., Seiça, R. M. F., & Oliveira, C. R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.012 · Cited by 92
Self-citationGlucagon like peptide-1 (GLP-1) likes Alzheimer’s disease
Simsir, I. Y., Soyaltın, U. E., & Çetinkalp, Ş. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.002 · Cited by 93
Candeias, E., Sebastião, I., Cardoso, S., Carvalho, C., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0622-3 · Cited by 89
Self-citationInsulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats
Moreira, P. I., Santos, M. S., Sena, C. M., Seiça, R. M. F., & Oliveira, C. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.017 · Cited by 89
Self-citationEffects of Type II diabetes on muscle microvascular oxygen pressures
Padilla, D. J., McDonough, P., Behnke, B. J., Kano, Y., Hageman, K. S., Musch, T. I., & Poole, D. C. (2006) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2006.08.008 · Cited by 84
Cheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84
Moreira, P. I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111127 · Cited by 83
Self-citationDrago, D., Cavaliere, A., Mascetra, N., Ciavardelli, D., Ilio, C. D., Zatta, P. F., & Sensi, S. L. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0761 · Cited by 74
Fujimaki, S., & Kuwabara, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102147 · Cited by 77
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Cullinane, P. W., Pablo‐Fernández, E. D., König, A., Outeiro, T. F., Jaunmuktane, Z., & Warner, T. T. (2022) · Movement Disorders · doi:10.1002/mds.29298 · Cited by 78
Avocado Oil Improves Mitochondrial Function and Decreases Oxidative Stress in Brain of Diabetic Rats
Ortiz‐Avila, O., Esquivel-Martínez, M., Olmos‐Orizaba, B. E., Saavedra‐Molina, A., Rodríguez-Orozco, A. R., & Cortés‐Rojo, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/485759 · Cited by 77
Brain Energy Metabolism in Ischemic Stroke: Effects of Smoking and Diabetes
Sifat, A. E., Nozohouri, S., Archie, S. R., Chowdhury, E. A., & Abbruscato, T. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158512 · Cited by 74
Martins, I. V. A., Rivers‐Auty, J., Allan, S. M., & Lawrence, C. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160640 · Cited by 70
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 80
Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 68
Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model
Niño, S. A., Morales-Martínez, A., Chi-Ahumada, É., Carrizales, L., Salgado‐Delgado, R., Pérez‐Severiano, F., Díaz-Cintra, S. Y., Jiménez-Capdeville, M. E., & Zarazúa, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00278 · Cited by 64
Silva, A. M., & Oliveira, P. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-382-0_2 · Cited by 64
Cheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 63
Ferreira, F. M. L., Seiça, R. M. F., Oliveira, P. J., Coxito, P. M., Moreno, A. J., Palmeira, C. M., & Santos, M. S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.08.001 · Cited by 61
Self-citationNeuroprotective effect ofH. perforatum extracts on β-amyloid-induced neurotoxicity
Silva, B. A., Dias, A. C. P., Ferreres, F., Malva, J. O., & Oliveira, C. R. (2004) · Neurotoxicity Research · doi:10.1007/bf03033214 · Cited by 58
Self-citationLietzau, G., Davidsson, W., Östenson, C., Chiazza, F., Nathanson, D., Pintana, H., Skogsberg, J., Klein, T., Nyström, T., Darsalia, V., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0517-1 · Cited by 58
Antidiabetic Drugs in Alzheimer’s Disease: Mechanisms of Action and Future Perspectives
Femminella, G. D., Bencivenga, L., Petraglia, L., Visaggi, L., Gioia, L., Grieco, F. V., de Lucia, C., Komici, K., Corbi, G., Edison, P., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7420796 · Cited by 57
Targeting Insulin Resistance to Treat Cognitive Dysfunction
Tyagi, A., & Pugazhenthi, S. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02283-3 · Cited by 59
Critical analysis of Alzheimer rsquo s amyloid-beta nbsp toxicity to mitochondria
Kaminsky, Y. G. (2015) · Frontiers in bioscience · doi:10.2741/4304 · Cited by 54
Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
Veselov, I. M., Vinogradova, D. V., Maltsev, A. V., Shevtsov, P. N., Spirkova, E. A., Бачурин, С. О., & Shevtsova, E. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914450 · Cited by 55
Impaired Insulin Signaling and Mechanisms of Memory Loss
Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 52
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Alzheimer's disease: Is this a brain specific diabetic condition?
Rani, V., Deshmukh, R. R., Jaswal, P., Kumar, P., & Bariwal, J. B. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.041 · Cited by 46
Erukainure, O. L., Ijomone, O. M., Sanni, O., Aschner, M., & Islam, M. S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00444-x · Cited by 49
Carvalho, C., Katz, P. S., Dutta, S., Katakam, P. V. G., Moreira, P. I., & Busija, D. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130464 · Cited by 42
Self-citationMorozov, Y. M., Dominguez, M. H., Varela, L., Shanabrough, M., Koch, M., Horváth, T. L., & RAKIC, P. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12237 · Cited by 43
Rehni, A. K., Nautiyal, N., Pérez‐Pinzón, M. A., & Dave, K. R. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9538-z · Cited by 43
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance
Al-Sayyar, A., Hammad, M. M., Williams, M. R., Al‐Onaizi, M., Abubaker, J. A., & Alzaïd, F. (2023) · Metabolites · doi:10.3390/metabo13030384 · Cited by 45
Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
Kale, M. B., Bhondge, H. M., Wankhede, N. L., Shende, P. V., Thanekar, R., Aglawe, M. M., Rahangdale, S. R., Taksande, B. G., Pandit, S. B., Upaganlawar, A. B., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102415 · Cited by 38
Santos, R. X., Correia, S. C., Alves, M. G., Oliveira, P. F., Cardoso, S., Carvalho, C., Seiça, R. M. F., Santos, M. S., & Moreira, P. I. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2076-5 · Cited by 38
Self-citationCandeias, E., Duarte, A. I., Sebastião, I., Fernandes, M. A. S., Plácido, A. I., Carvalho, C., Correia, S. C., Santos, R. X., Seiça, R. M. F., Santos, M. S., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0155-1 · Cited by 37
Self-citationOrtiz‐Avila, O., Figueroa–García, M. D. C., Garcia‐Berumen, C. I., Calderón‐Cortés, E., Mejía‐Barajas, J. A., Rodríguez-Orozco, A. R., Mejía‐Zepeda, R., Saavedra‐Molina, A., & Cortés‐Rojo, C. (2017) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9697-9 · Cited by 34
Effect of Gender on Mitochondrial Toxicity of Alzheimer's A β Peptide
Viña, J., Lloret, A., Vallés, S. L., Borrás, C., Badía, M.-C., Pallardó, F. V., Sastre, J., & Alonso, M.-D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1773 · Cited by 33
Erukainure, O. L., Ijomone, O. M., Oyebode, O. A., Chukwuma, C. I., Aschner, M., & Islam, M. S. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.03.044 · Cited by 30
Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso, S., Correia, S. C., Carvalho, C., & Moreira, P. I. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_3 · Cited by 29
Self-citationSilva, A. M., & Oliveira, P. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7831-1_2 · Cited by 29
Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
Cardoso, S., Correia, S. C., Santos, R. X., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040010 · Cited by 31
Self-citationMitochondria as Potential Targets in Antidiabetic Therapy
Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 27
Self-citationSperling, J. A., Sakamuri, S. S. V. P., Albuck, A. L., Sure, V. N. L. R., Evans, W. R., Peterson, N. R., Rutkai, I., Mostany, R., Satou, R., & Katakam, P. V. G. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08552-8 · Cited by 25
Billimoria, F. R., Katyare, S. S., & Patel, S. P. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00470.x · Cited by 25
Diabesity and Brain Energy Metabolism: The Case of Alzheimer’s Disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_5 · Cited by 24
Self-citationKwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 23
Iuchi, H., Sakamoto, M., Matsutani, D., Suzuki, H., Kayama, Y., Takeda, N., Minamisawa, S., & Utsunomiya, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12106-y · Cited by 20
Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
Moreira, P. I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170931 · Cited by 20
Self-citationTolerance to NADH/NAD+ imbalance anticipates aging and anti-aging interventions
Alonso-Lavin, A. J., Bajić, D., & Poyatos, J. F. (2021) · iScience · doi:10.1016/j.isci.2021.102697 · Cited by 17
The Rationale for Insulin Therapy in Alzheimer’s Disease
Ribarič, S. (2016) · Molecules · doi:10.3390/molecules21060689 · Cited by 20
Katyare, S. S., & Patel, S. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.02.012 · Cited by 14
The impact of diabetes mellitus on the development of psychiatric and neurological disorders
Kelly, O., Sullivan, J., Carris, N., Geci, S., Martinez, A., Liashenko, V., Colvin, J., Misko, E., Vanderlaan, G., He, L., et al. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100135 · Cited by 18
Ferreira, F. M. L., Peixoto, F., Nunes, E., Sena, C. M., Seiça, R. M. F., & Santos, M. S. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2424 · Cited by 13
Self-citationDiabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change
Ahmad, R., Chowdhury, K., Kumar, S., Irfan, M., Reddy, G. S., Akter, F., Jahan, D., & Haque, M. (2022) · Biology · doi:10.3390/biology11030382 · Cited by 14
A novel neurotrophic peptide: APP63-73
Wang, R., Zhang, J., Yang, F., Ji, Z., Chakraborty, G., & Sheng, S. (2004) · Neuroreport · doi:10.1097/00001756-200412030-00025 · Cited by 11
Affective and Cognitive Impairments in Rodent Models of Diabetes
Palazzo, E., Marabese, I., Boccella, S., Belardo, C., Pierretti, G., & Maione, S. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240124164804 · Cited by 10
Udomruk, S., Wudtiwai, B., Shwe, T. H., Phitak, T., Pothacharoen, P., Phimphilai, M., & Kongtawelert, P. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.012 · Cited by 10
Carvalho, C., & Moreira, P. I. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.011 · Cited by 10
Self-citationCarvalho, C., Correia, S. C., Seiça, R. M. F., & Moreira, P. I. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04508-7 · Cited by 10
Self-citationInsulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
Self-citationIn vitro salicylate does not further impair aging-induced brain mitochondrial dysfunction
Marques‐Aleixo, I., Rocha‐Rodrigues, S., Alves, E. S., Coxito, P. M., Passos, E., Oliveira, P. J., Magalhães, J., & Ascensão, A. A. M. R. (2012) · Toxicology · doi:10.1016/j.tox.2012.07.018 · Cited by 10
Etiopathogenesis and Pharmacological Prevention of a Type-2 Diabetes Model in Male Mice
Loizzo, A., Spampinato, S. M., Campana, G., & Loizzo, S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244707 · Cited by 6
1,3-Dinitrobenzene neurotoxicity – Passage effect in immortalized astrocytes
Maurer, L. L., Latham, J. D., Landis, R. W., Song, D. H., Epstein, T., & Philbert, M. A. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2015.11.011 · Cited by 5
Glucose Metabolism, Insulin, and Aging
Boemi, M., Furlan, G., & Luconi, M. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00029-7 · Cited by 5
Alzheimer’s Disease and Type 2 Diabetes: Different Pathologies and Same Features
Di, M., Picone, P., Carrotta, R., Giacomazza, D., & San, P. L. (2011) · InTech eBooks · doi:10.5772/24390 · Cited by 4
Long‐term hyperglycaemia decreases gastrocnemius susceptibility to permeability transition
Lumini‐Oliveira, J., Ascensão, A. A. M. R., Pereira, C. V., Magalhães, S., Marques, F., Oliveira, P. J., & Magalhães, J. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02267.x · Cited by 5
Standards requirements for systems biology approaches to health care: mitochondrial proteomics
Vásquez, G. B., Zullo, S. J., & Barker, P. E. (2004) · Mitochondrion · doi:10.1016/j.mito.2003.11.001 · Cited by 4
Mitochondria in Diabetes Mellitus
Lee, H. K. (2005) · Oxidative stress and disease · doi:10.1201/9781420028843.ch8 · Cited by 3
Metadata
- Authors
- Moreira, P. I., Santos, M. S., Moreno, A. M., Seiça, R., & Oliveira, C. R.
- Affiliations
- University of Coimbra (PT)
- Center for Neuroscience of Coimbra, Department of Zoology, University of Coimbra, Coimbra, Portugal
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-06-01
- Volume
- 52
- Issue
- 6
- Pages
- 1449-1456
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2119876958
- Cited by
- 117
- References
- 54
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 4 · 2013: 7 · 2012: 9
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- brain mitochondria, mitochondrial dysfunction, aging, amyloid-beta, Goto-Kakizaki rats, mitochondrial permeability transition pore, mitochondrial membrane potential, respiratory control ratio, ADP/O ratio, ATP/ADP ratio, calcium accumulation, neurodegeneration, Alzheimer's disease
- MeSH terms
- Adenine Nucleotides, Aging, Animals, Brain, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Membrane Potentials, Mitochondria, Oxygen Consumption, Rats, Mutant Strains, Reference Values, Amyloid beta-Peptides, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review